Controversies in the medical management of stroke.
D000925:Anticoagulants / Q000627:therapeutic use*; D001815:Bloodletting; D002544:Cerebral Infarction / Q000628:therapy; D002561:Cerebrovascular Disorders / Q000628:therapy*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000628:therapy; D002546:Ischemic Attack, Transient / Q000628:therapy; D009270:Naloxone / Q000627:therapeutic use; D012008:Recurrence; D014665:Vasodilator Agents / Q000627:therapeutic use; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D014665:Vasodilator Agents; D009270:Naloxone; D014859:Warfarin; D006493:Heparin